United States - English - NLM (National Library of Medicine)

par pharmaceutical inc. - mercaptopurine (unii: e7wed276i5) (mercaptopurine anhydrous - unii:pkk6muz20g) - mercaptopurine 50 mg - mercaptopurine tablets are indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen. the response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric or adult). mercaptopurine is not effective for prophylaxis or treatment of central nervous system leukemia. mercaptopurine is not effective in acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including hodgkins disease), or solid tumors. mercaptopurine tablets should not be used in patients whose disease has demonstrated prior resistance to this drug. in animals and humans, there is usually complete cross-resistance between mercaptopurine and thioguanine. mercaptopurine should not be used in patients who have a hypersensitivity to mercaptopurine or any component of the formulation.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - mercaptopurine (unii: e7wed276i5) (mercaptopurine anhydrous - unii:pkk6muz20g) - mercaptopurine 50 mg - mercaptopurine tablets are indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen. the response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric or adult). mercaptopurine is not effective for prophylaxis or treatment of central nervous system leukemia. mercaptopurine is not effective in acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including hodgkins disease), or solid tumors. mercaptopurine tablets should not be used in patients whose disease has demonstrated prior resistance to this drug. in animals and humans, there is usually complete cross-resistance between mercaptopurine and thioguanine. mercaptopurine should not be used in patients who have a hypersensitivity to mercaptopurine or any component of the formulation.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - mercaptopurine (unii: e7wed276i5) (mercaptopurine anhydrous - unii:pkk6muz20g) - mercaptopurine 50 mg

Canada - English - Health Canada

sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents

Canada - English - Health Canada

sandoz canada incorporated - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents